Orum Therapeutics, Inc. (KOSDAQ:475830)
South Korea flag South Korea · Delayed Price · Currency is KRW
23,100
0.00 (0.00%)
Aug 8, 2025, 3:30 PM KST

Orum Therapeutics Company Description

Orum Therapeutics, Inc., a biopharmaceutical company, engages in the research and development of pharmaceuticals for cancer and immune diseases.

The company focuses on degrader-antibody conjugate that combine antibody-drug conjugate with targeted protein degradation technology.

Its lead product candidate is ORM-1153, a GSPT1 protein degrader that targets hematologic malignancies.

The company was founded in 2016 and is based in Daejeon, South Korea.

Orum Therapeutics, Inc.
CountrySouth Korea
Founded2016
IndustryBiotechnology
SectorHealthcare
Employees20
CEOSung-Joo Lee

Contact Details

Address:
281-25 Munji-ro
Daejeon, 34050
South Korea
Phone82 4 2716 3030
Websiteorumrx.com

Stock Details

Ticker Symbol475830
ExchangeKOSDAQ
Fiscal YearJanuary - December
Reporting CurrencyKRW
ISIN NumberKR7475830006
SIC Code2834

Key Executives

NamePosition
Sung-Joo LeeChief Executive Officer
Martin Intae JeongChief Financial Officer